Wellington Management Group’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$168M Buy
4,343,977
+765,355
+21% +$26.8M 0.03% 423
2026
Q1
$138M Buy
3,578,622
+866,286
+32% +$32M 0.03% 463
2025
Q4
$96.3M Buy
2,712,336
+2,305,437
+567% +$64.8M 0.02% 557
2025
Q3
$5.84M Buy
406,899
+109,535
+37% +$1.3M ﹤0.01% 1396
2025
Q2
$2.14M Buy
297,364
+39,063
+15% +$217K ﹤0.01% 1568
2025
Q1
$1.55M Sell
258,301
-26,549
-9% -$208K ﹤0.01% 1611
2024
Q4
$2.22M Sell
284,850
-57,473
-17% -$573K ﹤0.01% 1547
2024
Q3
$3.7M Buy
342,323
+25,470
+8% +$248K ﹤0.01% 1407
2024
Q2
$2.67M Buy
316,853
+20,542
+7% +$156K ﹤0.01% 1456
2024
Q1
$1.99M Buy
296,311
+168,867
+133% +$1.04M ﹤0.01% 1523
2023
Q4
$749K Buy
+127,444
New +$977K ﹤0.01% 1672
2019
Q4
Sell
-183,242
Closed -$1.05M 2025
2019
Q3
$1.05M Hold
183,242
﹤0.01% 1714
2019
Q2
$1.92M Hold
183,242
﹤0.01% 1637
2019
Q1
$3.22M Hold
183,242
﹤0.01% 1490
2018
Q4
$3.23M Sell
183,242
-14,125
-7% -$418K ﹤0.01% 1507
2018
Q3
$8.13M Sell
197,367
-10,224
-5% -$576K ﹤0.01% 1348
2018
Q2
$11.9M Hold
207,591
﹤0.01% 1228
2018
Q1
$9.22M Buy
+207,591
New +$9.23M ﹤0.01% 1303

Other funds holding COGT

Wellington Management Group's COGT Position: Q2 2026 in Review

Wellington Management Group increased its Cogent Biosciences (COGT) stake by 21% in Q2 2026, buying an estimated $26.8M and bringing the position to 4,343,977 shares worth $168M. The position accounts for 0.03% of the portfolio, ranked #423.

Wellington Management Group first reported a position in COGT in Q1 2018 and has held it in 18 quarters since. 324 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Wellington Management Group held 4,343,977 shares of Cogent Biosciences worth $168M as of Q2 2026.
  • Wellington Management Group bought 765,355 Cogent Biosciences shares in Q2 2026, an estimated $26.8M.
  • Cogent Biosciences made up 0.03% of Wellington Management Group's portfolio in Q2 2026, its #423 holding.
  • Wellington Management Group first reported a position in Cogent Biosciences in Q1 2018 and has held it in 18 quarters since.
  • 324 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.